BRIEF published on 04/24/2025 at 14:05, 1 year 5 months ago Pentixapharm Signs Manufacturing Deal for Yttrium-90 Therapy Clinical Trials Eckert & Ziegler Radiopharmaceuticals Pentixapharm Yttrium-90
BRIEF published on 04/24/2025 at 14:05, 1 year 5 months ago Pentixapharm signe un accord de fabrication pour la thérapie à l'yttrium-90 Eckert & Ziegler Essais Cliniques Produits Radiopharmaceutiques Pentixapharm Yttrium-90
PRESS RELEASE published on 04/24/2025 at 14:00, 1 year 5 months ago Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE Pentixapharm signs manufacturing agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE to produce CXCR4-targeting radiotherapeutic doses for clinical trials Clinical Trials Eckert & Ziegler SE Pentixapharm Y90-PentixaTher Radiotherapeutic
BRIEF published on 04/15/2025 at 08:22, 1 year 5 months ago Pentixapharm Holding AG Reports 2024 Financial Results and 2025 Outlook Research And Development Financial Results 2024 2025 Financial Forecast Radiopharmaceutical Innovation Pentixapharm Strategy
BRIEF published on 04/15/2025 at 08:22, 1 year 5 months ago Pentixapharm Holding AG publie ses résultats financiers pour 2024 et ses perspectives pour 2025 Recherche Et Développement Résultats Financiers 2024 Prévisions Financières 2025 Innovation Radiopharmaceutique Stratégie Pentixapharm
PRESS RELEASE published on 04/15/2025 at 08:17, 1 year 5 months ago Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year Pentixapharm Holding AG releases 2024 financial results with EUR 12.8 million net loss and guides for EUR 23.5 million loss in 2025, focusing on R&D and operating expenses Financial Results 2024 Net Loss 2025 Pentixapharm
BRIEF published on 03/03/2025 at 14:43, 1 year 6 months ago Pentixapharm Holding AG Announces Board Changes Supervisory Board Board Changes Leadership Transition Pentixapharm Governance Dr. Andreas Eckert
BRIEF published on 03/03/2025 at 14:43, 1 year 6 months ago Pentixapharm Holding AG annonce des changements au sein de son conseil d'administration Conseil De Surveillance Transition De Direction Changements Au Sein Du Conseil D'administration Dr. Andreas Eckert Gouvernance De Pentixapharm
PRESS RELEASE published on 03/03/2025 at 14:38, 1 year 6 months ago Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG Personnel changes in both the Supervisory Board and Management Board of Pentixapharm Holding AG have been implemented as of March 1, 2025, aligning the boards of the parent and subsidiary companies Supervisory Board Management Board Berlin Personnel Changes Pentixapharm Holding AG
BRIEF published on 02/13/2025 at 14:15, 1 year 7 months ago Pentixapharm to Present Pioneering Bladder Cancer Treatment at ASCO-GU 2025 Bladder Cancer Lu177-PentixaTher CXCR4 Target ASCO-GU 2025 Radioligand Therapy
Published on 09/25/2026 at 00:30, 54 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 1 hour 9 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 3 hours 23 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 14:55, 10 hours 29 minutes ago Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 20:29, 4 hours 55 minutes ago EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 6 hours 24 minutes ago HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 6 hours 44 minutes ago EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Published on 09/24/2026 at 18:15, 7 hours 9 minutes ago Epanko Value Engineering Identifies 20% Production Increase
Published on 09/24/2026 at 18:05, 7 hours 19 minutes ago DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
Published on 09/24/2026 at 18:31, 6 hours 53 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 7 hours 24 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 7 hours 24 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
